IFN-γ not only inhibits HSC activation and ECM synthesis directly (20) but also amplifies NK-cell cytotoxicity against HSCs by promoting NKG2D expression on liver NK cells to attenuate liver fibrosis (21). Here, KLRK1 is linked to Hepatic fibrosis.